Cipla
Generic medicines, respiratory products and active pharmaceutical ingredients.
Cipla manufactures generic medicines, respiratory products and active pharmaceutical ingredients from its Mumbai operations. The company supplies retail, industrial, healthcare, foodservice or export customers across its listed primary markets.
- Type
- Manufacturer
- Location
- Mumbai, India
- Founded
- 1935
- Website
- cipla.com
- Categories
- Medical & Healthcare Supplies
- Markets
- India, United States, South Africa, United Arab Emirates
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- domain-registered (green), checked 2026-08-08 Domain registry record
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- customer-reviews (amber), checked 2026-08-08 MouthShut
- export-registered (green), checked 2026-08-21 Pharmexcil member directory (Pharmaceuticals Export Promotion Council of India, Ministry of Commerce)
- registered-manufacturer (green), checked 2026-08-21 Pharmexcil member directory (Pharmaceuticals Export Promotion Council of India, Ministry of Commerce)
- lei-active (green), checked 2026-08-23 GLEIF global LEI register (golden copy)
Claimed certifications
- Good Manufacturing Practice
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)